{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:22:34Z","timestamp":1790306554797,"version":"4.1.0"},"reference-count":37,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,26]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Recently, drug-coated balloons (DCB) have emerged as a promising alternative for side branch treatment in coronary bifurcation lesions, in combination with drug-eluting stent (DES) implantation in the main vessel, the hybrid DCB approach. We aimed to evaluate clinical outcomes in patients treated with the hybrid DCB approach and to compare this strategy with other bifurcation techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>MEDLINE and EMBASE were searched up until January 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>We included randomised controlled trials and observational studies investigating clinical outcomes in patients treated with the hybrid DCB approach for coronary bifurcation lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two independent reviewers extracted data and assessed the risk of bias. The outcome of interest was the combined endpoint of cardiac death, myocardial infarction (MI) or target lesion revascularisation (TLR) at the longest available follow-up. Crude event rates, stratified by treatment strategy, were provided for the overall incidence of the primary endpoint. Furthermore, we conducted meta-analyses on the combined endpoint, comparing different bifurcation percutaneous coronary intervention (PCI) strategies. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>13 studies, consisting of 2393 patients, were included in our systematic review. Investigated techniques were the hybrid DCB approach in all studies, and a two-stent strategy or the combination of DES in main vessel and balloon angioplasty (BA) in the side branch as potential comparators. Median follow-up duration was 12 months (IQR 7.5\u201312). The combined endpoint of cardiac death, MI or TLR was found in 5.6% in the hybrid DCB group, 15.4% in the two-stent group and in 10.0% in the BA group. The pooled analyses, including three and two studies, respectively, showed that the hybrid DCB approach was associated with a lower risk of the composite endpoint of cardiac death, MI or TLR when compared with a two-stent strategy (7.9% vs 15.4%; risk ratio (RR): 0.53; 95%\u2009CI 0.33 to 0.85)\u2009and compared with BA in the side branch (5.6% vs 10.0%; RR: 0.57; 95%\u2009CI 0.37 to 0.88). The certainty of the evidence was graded as very low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results of this systematic review and meta-analysis suggest that the hybrid DCB approach is a feasible and promising treatment approach for bifurcation lesions, when compared with other bifurcation PCI strategies. However, the results should be interpreted cautiously as the certainty of evidence was graded as very low, underlining the importance of larger trials to confirm these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CRD420250651469.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114024","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:10:25Z","timestamp":1773245425000},"page":"e114024","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9640-5026","authenticated-orcid":false,"given":"Daimy M M","family":"Dillen","sequence":"first","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad A J","family":"van Beek","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J E","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter-Jan","family":"Vlaar","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Farissi","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-7108","authenticated-orcid":false,"given":"Jesse P A","family":"Demandt","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Eerdekens","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van het Veer","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim A L","family":"Tonino","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Teeuwen","sequence":"additional","affiliation":[{"name":"Cardiology, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026062609360769000_16.3.e114024.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.664920"},{"key":"2026062609360769000_16.3.e114024.2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90631-V"},{"key":"2026062609360769000_16.3.e114024.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2126"},{"key":"2026062609360769000_16.3.e114024.4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcin.2007.12.008","article-title":"Bifurcation disease: what do we know, what should we do","volume":"1","author":"Latib","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"2026062609360769000_16.3.e114024.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.023"},{"key":"2026062609360769000_16.3.e114024.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.023"},{"key":"2026062609360769000_16.3.e114024.7","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1093\/eurheartj\/ehab283","article-title":"The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN)","volume":"42","author":"Hildick-Smith","year":"2021","journal-title":"Eur Heart J"},{"key":"2026062609360769000_16.3.e114024.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.1066"},{"key":"2026062609360769000_16.3.e114024.9","doi-asserted-by":"crossref","first-page":"e915","DOI":"10.4244\/EIJ-D-24-00160","article-title":"Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club","volume":"20","author":"Burzotta","year":"2024","journal-title":"EuroIntervention"},{"key":"2026062609360769000_16.3.e114024.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"2026062609360769000_16.3.e114024.11","first-page":"530","article-title":"Drug\u2010Coated Balloons Versus Non\u2010Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta\u2010Analysis","volume":"106","author":"Rocchetti","year":"2025","journal-title":"Cathet Cardio Intervent"},{"key":"2026062609360769000_16.3.e114024.12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.14744\/AnatolJCardiol.2025.5296","article-title":"Drug-Coated Balloons vs. Plain Balloon Angioplasty for Side Branch Management in Coronary Bifurcation Lesions: A Systematic Review and Meta-Analysis","volume":"29","author":"\u00d6zbay","year":"2025","journal-title":"Anatol J Cardiol"},{"key":"2026062609360769000_16.3.e114024.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251986","article-title":"Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis","volume":"16","author":"Corballis","year":"2021","journal-title":"PLoS ONE"},{"key":"2026062609360769000_16.3.e114024.14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(19)30474-X","article-title":"Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials","volume":"393","author":"Piccolo","year":"2019","journal-title":"The Lancet"},{"key":"2026062609360769000_16.3.e114024.15","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2026062609360769000_16.3.e114024.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026062609360769000_16.3.e114024.17","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-025-01087-1","article-title":"Beyond the Incision: Understanding Catheter Induced Coronary Artery Dissection","volume":"27","author":"Geeslin","year":"2025","journal-title":"Curr Treat Options Cardio Med"},{"key":"2026062609360769000_16.3.e114024.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026062609360769000_16.3.e114024.19","unstructured":"Wells GA , Shea B , O\u2019Connell D , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute,"},{"key":"2026062609360769000_16.3.e114024.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2024.08.067","article-title":"Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial","volume":"85","author":"Gao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026062609360769000_16.3.e114024.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.058"},{"key":"2026062609360769000_16.3.e114024.22","doi-asserted-by":"crossref","unstructured":"Pan L , Lu W , Han Z , et al . Drug-coated balloon in the treatment of coronary left main true bifurcation lesion: A patient-level propensity-matched analysis. Front Cardiovasc Med 2022;9. doi:10.3389\/fcvm.2022.1028007","DOI":"10.3389\/fcvm.2022.1028007"},{"key":"2026062609360769000_16.3.e114024.23","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6889836","article-title":"The \u201cL-Sandwich\u201d Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial","volume":"2023","author":"Guo","year":"2023","journal-title":"J Interv Cardiol"},{"key":"2026062609360769000_16.3.e114024.24","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8250057","article-title":"Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions","volume":"2022","author":"Liu","year":"2022","journal-title":"J Interv Cardiol"},{"key":"2026062609360769000_16.3.e114024.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.09.010"},{"key":"2026062609360769000_16.3.e114024.26","doi-asserted-by":"crossref","unstructured":"Prvulovi\u0107 \u0110 , Cortese B . Rationale and design of a prospective, open-label, randomized, multicentric clinical trial on the role of drug-coated balloons for bifurcation coronary lesions: the PRO-DAVID study. Top Ital sci j 2024;1. doi:10.62684\/EHOA4798","DOI":"10.62684\/EHOA4798"},{"key":"2026062609360769000_16.3.e114024.27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4244\/EIJ-D-23-00849","article-title":"Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions","volume":"20","author":"Yamamoto","year":"2024","journal-title":"EuroIntervention"},{"key":"2026062609360769000_16.3.e114024.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504133321507"},{"key":"2026062609360769000_16.3.e114024.29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/CM9.0000000000000743","article-title":"A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China","volume":"133","author":"Jing","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"2026062609360769000_16.3.e114024.30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4244\/EIJV11I8A177","article-title":"DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial","volume":"11","author":"Berland","year":"2015","journal-title":"EuroIntervention"},{"key":"2026062609360769000_16.3.e114024.31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.carrev.2021.12.020","article-title":"Impact of Late Lumen Loss on Clinical Outcomes of Side-Branch Bifurcation Lesions Treated by Drug-Coated Balloon Angioplasty With Main-Branch Stenting","volume":"41","author":"Ikuta","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"2026062609360769000_16.3.e114024.32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.carrev.2023.04.010","article-title":"Safety and Efficacy of a Hybrid Approach Combining a Paclitaxel-Coated Balloon With a New Generation Drug-Eluting Stent in Patients With De Novo True Coronary Bifurcation Lesions","volume":"54","author":"Kasbaoui","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"2026062609360769000_16.3.e114024.33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10557-021-07225-8","article-title":"Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention","volume":"36","author":"Li","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026062609360769000_16.3.e114024.34","doi-asserted-by":"crossref","first-page":"C79","DOI":"10.1093\/eurheartjsupp\/suad011","article-title":"Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study","volume":"25","author":"Pellegrini","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"2026062609360769000_16.3.e114024.35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carrev.2015.07.009","article-title":"Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study","volume":"16","author":"Worthley","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"2026062609360769000_16.3.e114024.36","doi-asserted-by":"crossref","first-page":"2161620","DOI":"10.1080\/14017431.2022.2161620","article-title":"A novel hybrid strategy of drug coated balloon and stent for coronary bifurcation lesions","volume":"57","author":"Yang","year":"2023","journal-title":"Scand Cardiovasc J"},{"key":"2026062609360769000_16.3.e114024.37","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.4244\/EIJ-D-24-00742","article-title":"Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial","volume":"21","author":"Zhou","year":"2025","journal-title":"EuroIntervention"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:39:53Z","timestamp":1782491993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-114024"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114024","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}